Mydacla or Mydekla (daclatasvir 60mg) modern antiviral agent, similar to the American Daklinza.
Manufactured by famous Indian pharmaceutical company Mylan.
One pack contains 28 tablets.
Mydekla is the generic of daclatasvir produced by Indian pharmaceutical company Mylan Pharma. Used to treat hepatitis C genotypes 1-4. It blocks the protein NS5A, which is required for virus replication. Due to this, HCV can spread from the liver cells into the bloodstream of the patient. It is as follows: daclatasvir interacts with the N-end element of the tertiary structure of the protein, breaks it, resulting in NS5A could not be involved in the replication of HCV
“Magala” is a highly specific tool, so it will not be effective in the treatment of HIV and other DNA – and RNA-containing viruses. Studies have shown that the drug is pangenotypic, that is effective in various types of HCV.
Generic ” Mydekla ” is used in the treatment of chronic hepatitis C, including in the presence of compensated cirrhosis and other liver diseases. A course of drug therapy may include sofosbuvir, asunaprevir, peginterferon Alfa, ribavirin (in accordance with the evolved genotype).
The use and dosage of the drug
It is recommended to consume one tablet containing 60 mg of daclatasvir (whether before, after or during meals). The tool is used as a component of drug therapy of hepatitis C. Generic ” Mydekla ” is displayed, if previous treatments have failed and when the patient is first assigned therapy.
The tool cannot be assigned to treat pregnant and lactating women, minor patients (because the drug’s effect on children and adolescents has not been studied). Also contraindications lactase deficiency, hypolactasia, glucose-galactose malabsorption, high sensitivity to the main or additional components of a generic. Combination with antiepileptic, antibacterial agents, systemic corticosteroids, and drugs based on Hypericum extract may cause reduction in the quantity of the main active substances of daclatasvir in the blood and, as a consequence, low effectiveness of the treatment. If the therapy includes asunaprevir, you also need to eliminate the use of moderate CYP3A4 inducers.
The medicine should not be used as the sole component of therapy, therefore, the selection of related tools it is necessary to examine instructions for their use, and existing contraindications. The course of treatment prescribed exclusively by a doctor !
The drug Mydekla should be removed in a dry dark place inaccessible to small children. Storage temperature should not exceed thirty degrees Celsius. The expiration date is on the package, after the initial drug is not used.
It is beneficial to buy Mydekla You can find the catalog of our website or by calling us. Prices on Mydekla specified in section product.